SynthesisAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

The Efficacy and Safety of GLP-1 RAs in the Modification of Cardiovascular Morbidity in Patients with Obesity Without Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials Involving 32,884 Patients.

Mohammad Tanashat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.